Ester-Functionalized Ionizable Lipids for Intramuscular mRNA Delivery
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
There is a need for ionizable lipids with improved potency and pharmacokinetics for intramuscular mRNA delivery, as existing amide-containing lipids do not meet the requirements for safety and efficacy.
Innovation Solution
Development of a new family of ester-functionalized ionizable lipids with specific structural variations that enhance the physicochemical properties of lipid nanoparticles (LNPs) for efficient mRNA delivery, including compounds of Formula I and their corresponding nanoparticles, colloids, and supramolecular structures.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If amide-containing ionizable lipids are used for intramuscular mRNA delivery, then the lipids can form stable lipid nanoparticles, but the potency and pharmacokinetics are insufficient for effective delivery
Solution Approach 1:
The patent changes the chemical functional group parameter from amide to ester, which fundamentally alters the physicochemical properties of the ionizable lipid. This parameter change results in enhanced potency and improved pharmacokinetics while maintaining LNP stability, directly resolving the contradiction between reliability and productivity in mRNA delivery
Solution Approach 2:
The patent creates a composite lipid structure combining ester functional groups with specific hydrophobic regions and ionizable groups. This composite material approach enables the lipid to simultaneously achieve stable self-assembly into LNPs and exhibit superior potency and pharmacokinetic properties for intramuscular mRNA delivery
2Strength
If ionizable lipids with permanent positive charge are used, then nucleic acid binding is enhanced, but toxicity increases
Solution Approach 1:
The patent employs a dynamic charge system where the ionizable lipid transitions from neutral at physiological pH to positively charged in acidic environments. This dynamic behavior allows the lipid to bind nucleic acids effectively in acidic compartments while maintaining neutral charge in blood circulation, thereby reducing toxicity while preserving binding capability
Solution Approach 2:
The patent utilizes pH-dependent parameter changes in the ionizable lipid structure, where the charge state changes with environmental pH. This enables conditional nucleic acid binding only in target acidic compartments, avoiding the continuous positive charge that causes toxicity in permanent cationic lipids
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The ester-functionalized lipids exhibit higher potency and faster pharmacokinetics, improving the delivery and expression of mRNA in vivo, with enhanced safety and efficacy compared to amide-containing analogues.
Implementation Method 1
The ionizable lipid contains one or more tertiary amines that become positively charged in acidic conditions to bind nucleic acids
Implementation Method 2
LNPs are formed through self-assembly of a set of lipid components that include an ionizable lipid
Implementation Method 3
The ionizable lipid contains one or more tertiary amines that become positively charged in acidic conditions to bind nucleic acids and includes hydrophobic regions to promote self-assembly into nano-sized particles
Data Source
AI summary
The present application relates to ionizable lipids that include ester functional groups. The present application further relates to compositions and uses thereof for the delivery of agents such as nucleic acids and drugs.